E
Actavia Life Sciences, Inc. RASP
$0.004 -$0.0285-87.69%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -98.48% 1.24% 467.37% -51.53% 3,037.06%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -98.20% 1.55% 57.42% -21.58% 2,667.97%
Operating Income 98.20% -1.55% -57.42% 21.58% -2,667.97%
Income Before Tax 97.69% 1.47% 2.02% 83.73% -1,504.49%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 97.69% 1.47% 2.02% 83.73% -1,504.49%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 97.69% 1.47% 2.02% 83.73% -1,504.49%
EBIT 98.20% -1.55% -57.42% 21.58% -2,667.97%
EBITDA -- -- -- -- --
EPS Basic 98.57% 75.00% 66.67% 98.04% -262.79%
Normalized Basic EPS 97.73% 80.00% 100.00% 96.88% -109.52%
EPS Diluted 98.57% 75.00% 33.33% 98.04% -488.89%
Normalized Diluted EPS 97.73% 80.00% 100.00% 96.88% -450.00%
Average Basic Shares Outstanding 31.14% 328.83% 326.19% 506.98% 754.06%
Average Diluted Shares Outstanding 31.14% 328.83% 326.19% 506.98% 246.11%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings